| Ytd | -48.50% | |
| 1y | -48.36% |
| Open | 5.83 | Prev Close | 5.89 | Low | 5.62 | High | 6.09 | Mkt Cap | 596.68M |
| Vol | 1.98M | Avg Vol | 2.01M | EPS | -2.18 | P/E | N/A | Forward P/E | -11.01 |
| Beta | 0.83 | Short Ratio | 13.70 | Inst. Own | 95.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 6.79 | 200-d Avg | 8.61 | 1yr Est | 28.80 |
SPRY News
NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
New York, New York--(Newsfile Corp. - August 31, 2026) - WHY: Rosen Law Firm, a global investor righ
New class action for ARS Pharmaceuticals Inc. urges investors to seek recovery for alleged securitie
A securities class action alleges ARS Pharmaceuticals' co-founder and CEO personally steered investo
New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that
LOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehol
LOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action law
New York, New York--(Newsfile Corp. - August 30, 2026) - WHY: Rosen Law Firm, a global investor righ
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
New York, New York--(Newsfile Corp. - August 29, 2026) - WHY: Rosen Law Firm, a global investor righ
New York, New York--(Newsfile Corp. - August 28, 2026) - WHY: Rosen Law Firm, a global investor righ
NEW YORK, Aug. 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP announces that
LOS ANGELES, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shar
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswi
New York, New York--(Newsfile Corp. - August 27, 2026) - WHY: Rosen Law Firm, a global investor righ
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds p
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been
If you purchased or acquired ARS securities between March 9, 2026, and June 24, 2026 and would like
NEW YORK, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogni
Wall Street called the missed CVS Caremark formulary date a "negative shock" — a securities class ac
New York, New York--(Newsfile Corp. - August 26, 2026) - WHY: Rosen Law Firm, a global investor righ
SAN DIEGO--(BUSINESS WIRE)---- $SPRY #ArsPharmaceutical--Robbins LLP reminds shareholders that a sec
New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP announces that
Eric Karas, ARS Pharmaceuticals' Chief Commercial Officer, is named as a defendant in a securities c
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
New York, New York--(Newsfile Corp. - August 25, 2026) - WHY: Rosen Law Firm, a global investor righ
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
LOS ANGELES, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shar
Notice to pension funds, asset managers, and fiduciaries holding ARS Pharmaceuticals (NASDAQ: SPRY):
PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Grabar Law
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
New York, New York--(Newsfile Corp. - August 24, 2026) - WHY: Rosen Law Firm, a global investor righ
NEW YORK, Aug. 24, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds p
New class action for ARS Pharmaceuticals Inc. urges investors to seek recovery for alleged securitie
A securities class action alleges ARS Pharmaceuticals misrepresented when expanded CVS Caremark cove
New York, New York--(Newsfile Corp. - August 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that
U.S. stock futures mixed, Dow down 0.1%. Swarmer Inc (NASDAQ: SWMR) shares drop 7% after reporting w
Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results
ARS Pharmaceuticals (NASDAQ:SPRY) reported second-quarter financial results on Thursday. The transcr
Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session
ARS Pharmaceuticals (NASDAQ:SPRY) reported quarterly losses of $(0.63) per share which missed the an
ARS Pharma (SPRY) co-founder Richard Lowenthal steps down as CEO. President Donn Casale succeeds him
ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-ris
Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f
ARS Pharma reaffirmed its 2027 breakeven target, cut expenses and gained Florida Medicaid access for
Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'
U.S. stocks traded mostly higher, with the Nasdaq Composite down 0.1%. Industrials jumped 2.5%, whil